BASEL, Switzerland–(BUSINESS WIRE)–Indivi, an independent TechBio company, today announced the closing of a CHF15 million financial investment round led by Ava Investors. The additional financial resources will accelerate the validation and deployment of precision medicine tools in early-phase neuroscience drug development, targeting Alzheimer’s disease (AD). “The field of neurodegeneration remains one of the toughest challenges … [Read more…]

Transformative alliance to Create the world-leading clinical infrastructure and breakthrough biotechnology to redefine the therapeutic landscape of sepsis. TOULOUSE, France & FULLERTON, Calif.–(BUSINESS WIRE)–ABIONYX Pharma, (FR0012616852 – ABNX), a next-generation biotechnology company developing breakthrough therapies for severe and underserved diseases, today announced it has entered advanced strategic discussions with IHU SEPSIS, the world’s first and … [Read more…]

  ROCHESTER, Minn.–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: RION LAUNCHES RION VET TO TRANSFORM ANIMAL HEALTH WITH FIRST-IN-CLASS BIOLOGIC THERAPEUTIC; APPOINTS INDUSTRY LEADER MARK HERTHEL AS CEO; ANNOUNCES SERIES A FULFILLMENT RION, a clinical-stage regenerative medicine company and global leader in exosome-based therapeutics, … [Read more…]

New integration modernizes prescription workflows and enhances patient safety through partnership with ScriptSure SAN FRANCISCO–(BUSINESS WIRE)–Vagaro, the leading software for businesses in beauty, wellness, and fitness, recently announced the launch of E-Prescribe, a new integration designed to modernize and simplify how medspas and other providers manage prescriptions. Developed in partnership with ScriptSure, the feature enables … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Tendinopathy Market – A Global and Regional Analysis: Focus on Treatment and Region – Analysis and Forecast, 2025-2035” has been added to ResearchAndMarkets.com’s offering. The global tendinopathy market is experiencing notable expansion, driven by the increasing prevalence of musculoskeletal disorders, heightened awareness about the condition, and advancements in pharmacological, regenerative, and biologic therapies. … [Read more…]

NEWNAN, Ga.–(BUSINESS WIRE)–ATF Medical, a leading provider of complex workers’ compensation care solutions, today announced the launch of its Catastrophic Care Advantage, a proactive offering designed to dramatically improve outcomes for catastrophic workplace injury claims while lowering costs for payers and employers. Catastrophic claims represent just 1% of workers’ compensation cases but account for up … [Read more…]

Promega MSI technology will aid in the identification of patients with microsatellite stable (MSS) endometrial carcinoma MADISON, Wis.–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate® MSI Dx Analysis System as a companion diagnostic designed to identify patients with microsatellite stable (MSS; defined as not MSI-high [not MSI-H]) endometrial carcinoma who … [Read more…]

Invest-NL, LIOF and several private investors join Brightlands Venture Partners and Sofinnova Partners in supporting the Dutch biotech firm’s growth MAASTRICHT, Netherlands–(BUSINESS WIRE)–Qorium, the Dutch biotechnology company pioneering cultivated leather, today announced it has secured a €22 million investment from Invest-NL and LIOF alongside existing investors Brightlands Venture Partners and Sofinnova Partners. An influential group … [Read more…]

New high-resolution camera detects fine and semi-transparent objects, paving the way for improved inspection processes, surgical and agricultural robots KYOTO, Japan–(BUSINESS WIRE)–Kyocera Corporation (President: Hideo Tanimoto; “Kyocera”)(TOKYO: 6971) has developed a Triple Lens AI-Based High-Resolution Depth Sensor for close imaging. The camera utilizes three lenses and proprietary AI to recognize semi-transparent, thin, and fine line-shaped … [Read more…]

INCHEON, Korea–(BUSINESS WIRE)–#EpisNexLab–Samsung Epis Holdings Co., Ltd. today announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on the development of next-generation biotechnology platforms. Epis NexLab will focus on transforming highly scalable core technologies into platforms for the discovery of diverse new drug candidates, including license-out or joint development with … [Read more…]